Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$637M |
| 2 |
Weyerhaeuser
WY
|
+$340M |
| 3 |
IQVIA
IQV
|
+$132M |
| 4 |
Halliburton
HAL
|
+$123M |
| 5 |
Dover
DOV
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.68B |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$708M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$460M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$293M |
| 5 |
Gilead Sciences
GILD
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Healthcare | 5.12% |
| 3 | Financials | 4.53% |
| 4 | Consumer Discretionary | 4.09% |
| 5 | Communication Services | 3.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3701
CALL
B&G Foods
BGS
$279M
| $436K | ﹤0.01% |
+13,700
| New | +$450K |
|
3702
Sunrun
RUN
$2.39B
| $436K | ﹤0.01% |
78,486
+72,158
| +1,140% | +$492K |
|
|
INFN
3703
PUT
DELISTED
Infinera Corporation Common Stock
INFN
| $436K | ﹤0.01% |
49,100
+9,200
| +23% | +$88.6K |
|
3704
AeroVironment
AVAV
$8.63B
| $435K | ﹤0.01% |
8,045
-7,778
| -49% | -$331K |
|
|
SGEN
3705
DELISTED
Seagen Inc. Common Stock
SGEN
| $435K | ﹤0.01% |
7,994
-64,345
| -89% | -$3.29M |
|
|
CRR
3706
CALL
DELISTED
Carbo Ceramics Inc.
CRR
| $435K | ﹤0.01% |
50,400
+18,200
| +57% | +$128K |
|
|
ENDP
3707
PUT
DELISTED
Endo International plc
ENDP
| $434K | ﹤0.01% |
50,700
+18,700
| +58% | +$180K |
|
|
GPT
3708
DELISTED
Gramercy Property Trust
GPT
| $434K | ﹤0.01% |
14,360
+2,242
| +19% | +$67.1K |
|
|
AXON
3709
Axon Enterprise
AXON
$43.7B
| $433K | ﹤0.01% |
19,129
-22,738
| -54% | -$532K |
|
3710
Nexstar Media Group
NXST
$5.87B
| $433K | ﹤0.01% |
6,940
-25,631
| -79% | -$1.58M |
|
|
IMMU
3711
PUT
DELISTED
Immunomedics Inc
IMMU
| $432K | ﹤0.01% |
30,900
+12,100
| +64% | +$121K |
|
3712
V2X
VVX
$2.62B
| $431K | ﹤0.01% |
13,952
-1,317
| -9% | -$40.8K |
|
|
CLLS
3713
Cellectis
CLLS
$269M
| $430K | ﹤0.01% |
+15,100
| New | +$391K |
|
3714
PUT
Raymond James Financial
RJF
$34.4B
| $430K | ﹤0.01% |
7,650
| – | – |
|
|
KANG
3715
PUT
DELISTED
iKang Healthcare Group, Inc.
KANG
| $430K | ﹤0.01% |
31,900
+2,600
| +9% | +$34.8K |
|
|
AZPN
3716
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $430K | ﹤0.01% |
6,858
-10,505
| -61% | -$659K |
|
3717
Helen of Troy
HELE
$695M
| $429K | ﹤0.01% |
4,427
-19,220
| -81% | -$1.85M |
|
|
KNDI
3718
Kandi Technologies Group
KNDI
$69.3M
| $428K | ﹤0.01% |
+74,403
| New | +$315K |
|
3719
PUT
Park Hotels & Resorts
PK
$2.92B
| $427K | ﹤0.01% |
15,510
-1,408
| -8% | -$37.7K |
|
3720
Rigel Pharmaceuticals
RIGL
$763M
| $427K | ﹤0.01% |
16,830
+513
| +3% | +$12.5K |
|
3721
ProShares Ultra Russell2000
UWM
$247M
| $427K | ﹤0.01% |
12,792
+12,392
| +3,098% | +$373K |
|
3722
Valley National Bancorp
VLY
$7.99B
| $427K | ﹤0.01% |
35,383
+7,431
| +27% | +$85.6K |
|
3723
Clearway Energy Class C
CWEN
$6.75B
| $426K | ﹤0.01% |
22,085
+14,957
| +210% | +$277K |
|
3724
Cerus
CERS
$474M
| $425K | ﹤0.01% |
155,389
+154,534
| +18,074% | +$379K |
|
|
AXE
3725
PUT
DELISTED
Anixter International Inc
AXE
| $425K | ﹤0.01% |
5,000
-500
| -9% | -$38.4K |
|
Similar funds
Barclays's Q3 2017 Portfolio in Review
As of Q3 2017, Barclays held 7,380 positions worth $97.1B, up 4% from $93.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays's Q3 2017 filing shows 424 new, 3,249 increased, 2,816 reduced and 405 closed positions. Its largest new stake was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M. The largest sale was Invesco QQQ Trust, an estimated $3.68B.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, up from 6.1% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2017 buy was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $637M increase.
- Barclays's biggest Q3 2017 reduction was Invesco QQQ Trust, cutting an estimated $3.68B.
- Barclays fully exited Reynolds American Inc in Q3 2017, selling an estimated $293M.
- Barclays's ten largest holdings make up 29% of its $97.1B portfolio in Q3 2017.
- Barclays opened 424 new positions and closed 405 in Q3 2017.
- Barclays's portfolio value rose 4% quarter-over-quarter to $97.1B.
Based on Barclays's 13F filing for Q3 2017, filed 14 Nov 2017.